Literature DB >> 18162764

The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.

Erinn Downs-Kelly1, John R Goldblum, Raj M Patel, Sharon W Weiss, Andrew L Folpe, Fredrick Mertens, Marybeth Hartke, Raymond R Tubbs, Marek Skacel.   

Abstract

Diagnosing myxoid soft tissue neoplasms can be challenging because of overlapping histologic features. Distinct chromosomal translocations have been identified in several myxoid sarcomas, including t(12;16)(q13;p11) FUS-DDIT3 in myxoid liposarcoma, t(7;16)(q34;p11) FUS-CREB3L2 in low-grade fibromyxoid sarcoma, and t(9;22)(q31;q12) EWSR1-NR4A3 in extraskeletal myxoid chondrosarcoma. These recurrent chromosomal alterations are attractive targets for diagnostic studies. To that end, dual-color, break-apart fluorescence in situ hybridization (FISH) probes spanning the genomic regions of EWSR1 (22q12), DDIT3 (12q13), and FUS (16p11) (Vysis, Downer's Grove, IL) were evaluated in formalin-fixed, paraffin-embedded tissues from myxoid neoplasms, including intramuscular myxoma (n=10), myxoid liposarcoma (n=18), low-grade fibromyxoid sarcoma (n=10), extraskeletal myxoid chondrosarcoma (n=13), and myxofibrosarcoma (n=8). Of the myxoid liposarcomas, 18/18 cases had a rearrangement of the DDIT3 gene, with 17/18 (94.4%) showing both DDIT3 and FUS gene rearrangements. A FUS gene rearrangement was identified in 7/10 (70%) of low-grade fibromyxoid sarcomas, with no changes involving EWSR1 or DDIT3. An EWSR1 translocation was seen in 6/13 (46.2%) of extraskeletal myxoid chondrosarcomas, without changes in DDIT3 or FUS genes. The remaining neoplasms studied showed no rearrangements involving DDIT3, FUS, or EWSR1 genes. In conclusion, interphase FISH using DDIT3 and FUS probes identifies the characteristic translocation in myxoid liposarcoma. FUS and EWSR1 probes are useful in confirming the diagnosis of low-grade fibromyxoid sarcoma and extraskeletal myxoid chondrosarcoma, respectively. The specificity of the probes is documented as none of the non-translocation-associated myxoid tumors showed genomic abnormalities with the probes tested. FISH is capable of providing specific ancillary information useful in this often difficult differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18162764     DOI: 10.1097/PAS.0b013e3181578d5a

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  16 in total

Review 1.  Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems.

Authors:  Fausto J Rodriguez; Andrew L Folpe; Caterina Giannini; Arie Perry
Journal:  Acta Neuropathol       Date:  2012-02-12       Impact factor: 17.088

Review 2.  Fibromyxoma of the Jaw: Case Report and Review of the Literature.

Authors:  Thabet Alhousami; Amarpreet Sabharwal; Shivane Gupta; Alfredo Aguirre; Etern Park; Jill M Kramer
Journal:  Head Neck Pathol       Date:  2017-05-16

3.  Low-grade fibromyxoid sarcoma, a deceptively benign tumor in a 5-year-old child.

Authors:  Seema Menon; Michael Krivanek; Ralph Cohen
Journal:  Pediatr Surg Int       Date:  2011-12-01       Impact factor: 1.827

Review 4.  The benefits of molecular pathology in the diagnosis of musculoskeletal disease : part I of a two-part review: soft tissue tumors.

Authors:  Adrienne M Flanagan; David Delaney; Paul O'Donnell
Journal:  Skeletal Radiol       Date:  2010-02       Impact factor: 2.199

5.  Renal cell carcinomas with t(6;11)(p21;q12) presenting with tubulocystic renal cell carcinoma-like features.

Authors:  Qiu Rao; Xiu-Mei Zhang; Pin Tu; Qiu-Yuan Xia; Qin Shen; Xiao-Jun Zhou; Qun-Li Shi
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

6.  Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.

Authors:  Hiroaki Kimura; Yoh Dobashi; Takayuki Nojima; Hiroyuki Nakamura; Norio Yamamoto; Hiroyuki Tsuchiya; Hiroko Ikeda; Seiko Sawada-Kitamura; Takeru Oyama; Akishi Ooi
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

Review 7.  [Modern morphological diagnosis and current classification of soft tissue sarcomas].

Authors:  D Katenkamp; K Katenkamp
Journal:  Chirurg       Date:  2009-03       Impact factor: 0.955

8.  NY-ESO-1 as a diagnostic and prognostic marker for myxoid liposarcoma.

Authors:  Uiree Jo; Jin Roh; Min Jeong Song; Kyung-Ja Cho; Wanlim Kim; Joon Seon Song
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

9.  Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy.

Authors:  Wei-Lien Wang; Daniela Katz; Dejka M Araujo; Vinod Ravi; Joseph A Ludwig; Jonathan C Trent; Shreyaskumar R Patel; Patrick P Lin; Ashleigh Guadagnolo; Dolores Lòpez-Terrada; Angelo Paola Dei Tos; Valerie O Lewis; Dina Lev; Raphael E Pollock; Gunar K Zagars; Robert S Benjamin; John E Madewell; Alexander J Lazar
Journal:  Clin Sarcoma Res       Date:  2012-12-29

Review 10.  Contributions of cytogenetics and molecular cytogenetics to the diagnosis of adipocytic tumors.

Authors:  Jun Nishio
Journal:  J Biomed Biotechnol       Date:  2011-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.